Medical device company Medtronic is about to acquire peel-and-stick medical sensor company Corventis for some $150 million, MobiHealthNews is reporting. Neither company has publicly commented on the deal, but it is expected to be officially announced in the next few weeks.
Corventis makes FDA-approved peel-and-stick sensor called PiiX, which can measure a range of vital signs including fluid status, heart rate, HRV, respiratory rate, activity, posture, and more.
In 2010, Corventis secured approval from the Centers for Medicaid and Medicare (CMS) for its monitoring facility and could bill for services provided to patients with Medicare.
Corventis makes FDA-approved peel-and-stick sensor called PiiX, which can measure a range of vital signs including fluid status, heart rate, HRV, respiratory rate, activity, posture, and more.
In addition to the U.S., the company has also attempted to gain traction in India, where it introduced Nuvant in 2012.
Corventis’ investors include Kleiner Perkins Caufield Buyer, Mohr Davidow Ventures, DAG Ventures, and PTV Sciences.